About Childhood Cancer
Prognosis & Treatment
Childhood Cancer in Australia: Treatment and Prognosis
Childhood cancer, though rare, is one of the leading causes of disease-related death among Australian children. Each year, around 1,000 children and adolescents are diagnosed, and their journey depends heavily on timely treatment and access to specialised care. Thankfully, advances in modern medicine have dramatically improved outcomes, with many children now surviving and thriving beyond their diagnosis.
Understanding Childhood Cancers
Childhood cancers differ from adult cancers—they often grow rapidly but also respond well to intensive treatments. The most common types in Australia include:
- Leukaemia – the most common, affecting blood and bone marrow
- Brain and central nervous system tumours
- Lymphomas – Hodgkin and non-Hodgkin
- Neuroblastoma – affecting nerve cells
- Bone cancers – osteosarcoma and Ewing sarcoma
- Wilms tumour – kidney cancer
While the causes remain largely unknown, genetic factors and, in some cases, environmental exposures may play a role.
Treatment Approaches
Australia’s paediatric oncology centres provide multidisciplinary, evidence-based care, tailoring treatment plans to each child. Treatments are often combined and sequenced carefully to maximise effectiveness while reducing long-term side effects.
Chemotherapy
Chemotherapy remains the backbone of childhood cancer treatment, particularly for leukaemias and lymphomas. Administered orally, intravenously, or via injection into the spinal fluid, it targets rapidly dividing cancer cells.
Surgery
Surgery is commonly used to remove solid tumours. Paediatric surgeons work carefully to excise tumours while preserving healthy tissue, organ function, and growth potential.
Radiation Therapy
Radiotherapy uses high-energy beams to kill cancer cells. In children, treatment plans are meticulously calculated to minimise effects on growing tissues and developing organs.
Targeted and Immunotherapies
Targeted therapies attack specific molecules or pathways in cancer cells, reducing damage to healthy cells. Immunotherapies stimulate the child’s immune system to recognise and destroy cancer cells. These treatments are increasingly used for hard-to-treat cancers and relapsed disease.
Stem Cell and Bone Marrow Transplants
High-risk or relapsed leukaemias often require bone marrow or stem cell transplants. Intensive chemotherapy or radiation destroys the child’s diseased bone marrow, followed by transplantation to restore healthy blood cell production.
Prognosis
Prognosis has improved dramatically over the past 50 years. Today, over 80% of Australian children with cancer survive at least five years, and many are cured completely.
Survival rates depend on factors such as cancer type, stage at diagnosis, age, and response to treatment. For example:
- Acute lymphoblastic leukaemia (ALL): survival rates exceed 90%
- Hodgkin lymphoma: over 95% five-year survival
- High-grade brain tumours: more challenging, with lower survival, highlighting the need for ongoing research
Even after successful treatment, children may face late effects such as heart or lung issues, fertility challenges, or cognitive changes. Long-term follow-up care is essential to monitor and manage these effects.
Life Beyond Cancer
Many survivors go on to live full, healthy lives, attending school, pursuing careers, and building families. Support services—from counselling to educational assistance—help children and families navigate the emotional and practical challenges of survivorship.
The Role of Research and Support
Ongoing research in Australia focuses on improving survival, reducing side effects, and developing innovative therapies such as gene-targeted treatments and personalised immunotherapy. Community support through fundraising, volunteering, and advocacy provides essential resources for research, family support, and clinical trials.
Conclusion
Treatment for childhood cancer in Australia is highly advanced, combining chemotherapy, surgery, radiotherapy, targeted therapies, and transplantation to improve outcomes. Prognosis has never been better, with most children surviving and many achieving complete remission. Continued research, specialised care, and community support are crucial to ensuring that every child diagnosed with cancer has the best possible chance to not only survive but thrive.